pifithrin has been researched along with Clinically Isolated CNS Demyelinating Syndrome in 1 studies
pifithrin: a tetrahydrobenzothiazol; inhibitor of P53 that protects mice from the side effects of cancer therapy; structure in first source
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, J | 1 |
| Ghiani, CA | 1 |
| Kim, JY | 1 |
| Liu, A | 1 |
| Sandoval, J | 1 |
| DeVellis, J | 1 |
| Casaccia-Bonnefil, P | 1 |
1 other study available for pifithrin and Clinically Isolated CNS Demyelinating Syndrome
| Article | Year |
|---|---|
Inhibition of p53 transcriptional activity: a potential target for future development of therapeutic strategies for primary demyelination.
Topics: Animals; Benzothiazoles; Cells, Cultured; Cuprizone; Demyelinating Diseases; Disease Models, Animal; | 2008 |